This HTML5 document contains 157 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33364607
rdf:type
wikibase:Item
schema:description
2005年論文 scientific article artikull shkencor บทความทางวิทยาศาสตร์ научна статия artigo científico naučni članak vědecký článek mokslinis straipsnis επιστημονικό άρθρο artigo científico (publicado na 2005) 2005年论文 tudományos cikk 2005 nî lūn-bûn scienca artikolo мақолаи илмӣ 2005年论文 2005年の論文 2005年論文 2005年論文 wissenschaftlicher Artikel wetenschappelijk artikel vedecký článok vitenskapelig artikkel 2005년 논문 мақолаи илмӣ article scientifique (publié 2005) vetenskaplig artikel 2005年論文 teaduslik artikkel مقالة علمية სამეცნიერო სტატია videnskabelig artikel (udgivet 2005) 2005年论文 ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific artículu científicu espublizáu en 2005 vitskapeleg artikkel artikulong pang-agham article scientific 2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած artigo científico (publicado na 2005) научная статья 2005 թվականի փետրվարին հրատարակված գիտական հոդված bilimsel makale سائنسی مضمون 2005年論文 2005年论文 tieteellinen artikkeli מאמר מדעי 2005年论文 artykuł naukowy 2005年论文 научни чланак article científic bài báo khoa học مقالهٔ علمی наукова стаття, опублікована в лютому 2005 articolo scientifico artículo científico publicado en 2005 научни чланак
p:P577
wds:Q33364607-22AFC222-4C0D-4C31-A8C1-C2099C4148FE
wdt:P577
2005-02-01T00:00:00Z
p:P407
wds:Q33364607-078FC565-BB14-418C-844E-6EB6B0884178
wdt:P407
wd:Q1860
p:P2860
wds:Q33364607-55B4A011-E51D-4937-A0AC-6158695FCA31 wds:Q33364607-5D1CFFCE-2AF8-46C5-BA79-11A2922B2E5F wds:Q33364607-69FBBA28-5A5F-407D-B3D5-B28A3F975726 wds:Q33364607-B5CC19A9-D5FC-445C-B169-80797B6C0C5B wds:Q33364607-C9E65A09-CAA8-4205-BEB8-5D376F8DE577 wds:Q33364607-AA3DD01D-76AD-404C-A23D-60A6FE903FF3 wds:Q33364607-E975BC28-EF57-4826-B5EB-76FB83AF38B8 wds:Q33364607-EBF05C3B-4058-42EB-898F-EB14100D8496 wds:Q33364607-EBF3678E-2BB3-44EA-842F-25D619109DD2 wds:Q33364607-D1E87A09-F951-489A-8B8C-DC7F8934BB75 wds:Q33364607-D2925180-05FC-4BC3-8380-7D5666058E40 wds:Q33364607-DD606AAB-DF11-43C0-A10C-F9C2ECFA035B wds:Q33364607-00B5B6E5-F69A-49AF-9610-30AE95EA5304 wds:Q33364607-0BCC80F3-C94B-4941-AB86-EB643E0109A5 wds:Q33364607-13D47BF7-7753-4311-A4BF-40094043BA6A wds:Q33364607-031C315C-40C4-4829-BD68-0DDF6DA6DCB3 wds:Q33364607-F8619428-6F2A-434C-B8FC-6AE344FF8518 wds:Q33364607-2D068785-FCCE-4FA2-AE70-D4EB8EE6C5D8 wds:Q33364607-18967BD3-18ED-4679-A9AC-478672A648C8
wdt:P2860
wd:Q53558960 wd:Q33319678 wd:Q33490971 wd:Q57265736 wd:Q33429552 wd:Q28372733 wd:Q33345862 wd:Q33345866 wd:Q33339149 wd:Q44583516 wd:Q31962966 wd:Q33856411 wd:Q33336635 wd:Q73948160 wd:Q33337193 wd:Q54272955 wd:Q33346803 wd:Q67993403 wd:Q77706003
p:P2093
wds:Q33364607-0113CECC-6573-40C9-BFF9-12A5CCC47A5E wds:Q33364607-023F7E54-A872-488A-88EF-6E1BE3A78270 wds:Q33364607-15C5BEB2-5D06-4CEE-B073-FAA52924748F wds:Q33364607-127B4F4F-F4F2-42E5-AFEA-BF9E45E6B1F2 wds:Q33364607-9AF18A8E-1333-4B78-B492-74928B53A26C wds:Q33364607-4528E8E2-77F0-4FF0-B9CD-3A2652F1F035 wds:Q33364607-279F4927-F865-4F0A-BBC7-799B2487E2A0 wds:Q33364607-648203C1-F87B-41A2-AB1B-DAA500A0FBF0 wds:Q33364607-6FCC8192-A016-425D-BBD6-BF4F2D150B04
wdt:P2093
P Saip T Minarik E Fitzthum M F Kose J Sufliarsky A Melemed A Hayden S Beslija K Krejcy
rdfs:label
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma
skos:prefLabel
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma
schema:name
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma
p:P50
wds:Q33364607-B01FC12D-56D1-4D87-939E-D14163CD1D0F
wdt:P50
wd:Q57073782
p:P1476
wds:Q33364607-75B3D434-8573-401E-9FB2-AE2305274BC4
wdt:P1476
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma
p:P304
wds:Q33364607-AC126912-9F5A-4C19-9D94-CC3DA5BB21B1
wdt:P304
374-380
p:P31
wds:Q33364607-A784B0CD-AD13-4568-8CFE-32E7C7D9CD36
wdt:P31
wd:Q13442814
p:P921
wds:Q33364607-87A533BE-C6F9-4689-95B8-C3B6A40D4566 wds:Q33364607-1F7F0D7D-18B0-4BE0-B0E8-46C76034AECB wds:Q33364607-CB041850-4890-4EF9-93EA-35567C929AE9
wdt:P921
wd:Q880 wd:Q18556145 wd:Q415588
p:P698
wds:Q33364607-3191E7CA-FA84-4490-8D58-1C54AB31E655
wdtn:P698
n10:15661224
wdt:P698
15661224
p:P1433
wds:Q33364607-BCA2AA2F-30C8-44C4-B889-27E08AEA335D
wdt:P1433
wd:Q5625182
p:P433
wds:Q33364607-7CB98383-D76E-420C-83BD-80933557400A
p:P478
wds:Q33364607-184C9DBE-96F1-4229-8D2F-8080A45208D7
wdt:P433
2
wdt:P478
96
p:P356
wds:Q33364607-E90F1161-4D57-435B-8922-F135A06F6202
wdtn:P356
n9:J.YGYNO.2004.10.011
wdt:P356
10.1016/J.YGYNO.2004.10.011